TMS for Chronic Pain: How TMS Addresses Neuropathic Pain

Living with chronic neuropathic pain can feel relentless.

That burning, shooting, electric, or pins-and-needles sensation from damaged nerves doesn’t just hurt—it disrupts sleep, work, and even simple daily tasks.

Common causes include diabetic neuropathy, pain after shingles (post-herpetic neuralgia), nerve injuries from accidents or surgery, trigeminal neuralgia, or pain following a stroke.

Unlike psychosomatic pain, which stems primarily from psychological factors and emotional stress (even though it can feel very real), neuropathic pain has a clear physical origin: actual damage or dysfunction in the nerves themselves.

This distinction matters because treatments need to target those overactive or damaged nerve pathways directly.

That’s where Transcranial Magnetic Stimulation (TMS) comes in.

TMS is a non-invasive treatment that uses gentle magnetic pulses to stimulate specific areas of the brain involved in processing pain signals.

There’s no surgery, no needles, and no medications that affect your whole body.

While TMS is FDA-cleared for depression, a growing number of studies suggest it can also help reduce neuropathic pain.

How TMS Helps with Neuropathic Pain

TMS typically targets the primary motor cortex (M1), a region of the brain that plays a key role in modulating pain signals.

During a session, a small magnetic coil is placed against your head.

You feel a series of quick, painless clicks—like the soft snapping of fingers near your scalp.

Most people describe it as mildly noticeable but not painful.

A typical session lasts about 30–45 minutes, and a full course usually involves 20–30 sessions spread over 4–6 weeks.

Many patients then move to less frequent “maintenance” sessions to help sustain the relief.

Recent research supports its potential:

  • A real-world study in France followed patients with drug-resistant neuropathic pain who received multiple TMS sessions. It found that the treatment was safe and provided meaningful, lasting pain relief for many participants (Thomas et al., 2025).
  • A 2024 randomized controlled trial tested high-frequency TMS guided by brain navigation in patients with upper limb neuropathic pain. Those who received real treatment reported significantly lower pain levels compared to the sham group (Mori et al., 2024).
  • Ongoing research at UCSF is investigating personalized TMS protocols for various types of chronic neuropathic pain, including post-stroke pain and nerve injuries, with early results showing promise for reducing pain intensity (UCSF Clinical Trial, ongoing as of 2025–2026).

Studies like these suggest that TMS can reduce pain by 30–50% in many cases—enough to make a noticeable difference in daily life.

Access and Insurance in California

TMS clinics are widely available across California, especially in major cities.

For depression, TMS is often covered by insurance, including Medi-Cal.

For chronic neuropathic pain alone, however, it is considered an off-label use, which means most insurance plans—including Medi-Cal—typically do not cover it unless there is a qualifying comorbid condition (such as treatment-resistant depression).

Out-of-pocket costs usually range from $300–$500 per session, though some clinics offer payment plans or financing.

Our team can help you understand your specific insurance situation and explore any possible coverage options.

If neuropathic pain has been wearing you down, TMS offers a gentle, research-backed alternative worth considering.

You don’t have to keep suffering in silence.

We’re here to help—reach out to our clinic to talk about whether TMS might be a good fit for you.

Disclaimer

TMS for chronic neuropathic pain is supported by emerging research but is not currently FDA-cleared specifically for this indication.

Individual results vary, and not everyone responds to treatment.

Always consult with a qualified healthcare provider to determine if TMS is appropriate for your situation.

This article is for informational purposes only and is not a substitute for professional medical advice.

Citations

  • Mori, N., Hosomi, K., Nishi, A., et al. (2024). Repetitive transcranial magnetic stimulation focusing on patients with neuropathic pain in the upper limb: A randomized sham-controlled parallel trial. Scientific Reports, 14, 11811.
  • Thomas (lead author) et al. (2025). Effects of multiple transcranial magnetic stimulation sessions on pain relief in patients with chronic neuropathic pain: A French cohort study in real-world clinical practice. European Journal of Pain.
  • University of California, San Francisco (UCSF). (Ongoing, 2025–2026). Transcranial Magnetic Stimulation for Chronic Neuropathic Pain (Clinical Trial NCT05593237).

 

Leave A Comment

Your email address will not be published. Required fields are marked *